Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals (ARWR) Stock Price & Analysis


ARWR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$23.09 - $48.48
Previous Close$34.41
Average Volume (3M)1.17M
Market Cap
Enterprise Value$3.12B
Total Cash (Recent Filing)$481.00M
Total Debt (Recent Filing)$82.78M
Price to Earnings (P/E)-24.1
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.43
Shares Outstanding106,900,421
10 Day Avg. Volume938,628
30 Day Avg. Volume1,171,768
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)25.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.45
Enterprise Value/Gross Profit12.85
Enterprise Value/Ebitda-32.52
Price Target Upside64.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Arrowhead Pharmaceuticals’s price range in the past 12 months?
Arrowhead Pharmaceuticals lowest stock price was $23.09 and its highest was $48.48 in the past 12 months.
    What is Arrowhead Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Arrowhead Pharmaceuticals’s upcoming earnings report date?
    Arrowhead Pharmaceuticals’s upcoming earnings report date is Aug 03, 2023 which is in 62 days.
      How were Arrowhead Pharmaceuticals’s earnings last quarter?
      Arrowhead Pharmaceuticals released its earnings results on May 02, 2023. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of -$0.618 by $1.068.
        Is Arrowhead Pharmaceuticals overvalued?
        According to Wall Street analysts Arrowhead Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Arrowhead Pharmaceuticals pay dividends?
          Arrowhead Pharmaceuticals does not currently pay dividends.
          What is Arrowhead Pharmaceuticals’s EPS estimate?
          Arrowhead Pharmaceuticals’s EPS estimate is -$0.61.
            How many shares outstanding does Arrowhead Pharmaceuticals have?
            Arrowhead Pharmaceuticals has 106,900,420 shares outstanding.
              What happened to Arrowhead Pharmaceuticals’s price movement after its last earnings report?
              Arrowhead Pharmaceuticals reported an EPS of $0.45 in its last earnings report, beating expectations of -$0.618. Following the earnings report the stock price went up 13.624%.
                Which hedge fund is a major shareholder of Arrowhead Pharmaceuticals?
                Among the largest hedge funds holding Arrowhead Pharmaceuticals’s share is Woodline Partners LP. It holds Arrowhead Pharmaceuticals’s shares valued at 15M.


                  Arrowhead Pharmaceuticals Stock Smart Score

                  The Arrowhead Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Arrowhead Pharmaceuticals

                  Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.


                  Top 5 ETFs holding ARWR

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity MSCI Health Care Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold ARWR. The ETFs are listed according to market value of ARWR within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Alnylam Pharma
                  Editas Medicine
                  Intellia Therapeutics
                  Crispr Therapeutics AG

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis